MYSTERIOUS: 3 - You Need To See This

The woman who turned down her share of a $6bn settlement to fight the family behind the opioid crisis

Ellen Isaacs is intent on holding Purdue Pharma and the Sackler family to account – for the deaths of her son and many thousands of others

The Guardian - US · Apr 10, 2022

British Museum to remove Sackler name from galleries, rooms

One of the world’s most prestigious museums is removing the Sackler name from its galleries.

Tribune News Service · Mar 26, 2022

Yale strikes Sackler name from campus amid opioid outrage

Yale University has begun removing the Sackler name from its campus several years after announcing it would no longer accept donations from the family that owns OxyContin maker Purdue Pharma

The Independent UK · Mar 11, 2022

Patrick Radden Keefe on exposing the Sackler family’s links to the opioid crisis

The journalist tracked the billionaire arts philanthropists’ role in the OxyContin scandal in his gripping bestseller. He talks about why the bad guys are still getting away with it

The Guardian - UK · Feb 27, 2022

OxyContin victims fight for their share in Purdue bankruptcy case

The Sacklers want protection from future suits. Victims’ families want them to ‘know what their greed has caused’

The Guardian - US · Feb 27, 2022

Mediator: Sacklers willing to pay more in Purdue settlement

A report filed in federal bankruptcy court says members of the Sackler family who own Purdue Pharma are willing to increase their contribution to a nationwide opioid settlement by more than $1 billion

The Independent UK · Feb 18, 2022

Purdue’s Sacklers boost opioid settlement offer up to $6 billion

Members of the billionaire Sackler family that own Purdue Pharmacy LP have offered to pay as much as $6 billion to revive the OxyContin maker’s imperiled opioid settlement, a court-appointed mediator said in a report Friday.

Tribune News Service · Feb 18, 2022

Purdue’s Sacklers consider adding another $1 billion to opioid settlement

Members of the billionaire Sackler family that own Purdue Pharma LP are weighing whether to add $1 billion to the OxyContin-maker’s faltering opioid settlement bid in an effort to win over holdouts, according to people familiar with the talks.

Tribune News Service · Feb 11, 2022

Victims of opioids stand to get nothing

A former member of the creditors committee managing Purdue's bankruptcy speaks out about deliberations

Salon · Jan 25, 2022